cro.directory
← Compare landing

STEMCELL Technologies Inc. vs TRiCBIO

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategorySTEMCELL Technologies Inc.TRiCBIO
SummarySTEMCELL Technologies develops and sells cell culture media, cell separation systems, instruments, and reagents for life sciences research, plus contract research services including biopharmaceutical testing, cell characterization, toxicity testing, and organoid assays.TRiCBIO provides human organoid research services for efficacy, safety, mechanism and immune-context studies using PDO 2.0 and ALI platforms, supporting biopharma and CRO teams in candidate evaluation and translational research.
Services
  • Discovery Research
  • Preclinical In Vitro Studies
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Translational Research
  • Immunology & Inflammation Services
  • Discovery Research
  • Target Identification & Validation
  • Medicinal Chemistry
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Biomarker Assays
  • Flow Cytometry Services
  • Translational Research
Modalities
  • Cell Therapy
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
Indications
  • Oncology
  • Immunology
  • Oncology
  • Immunology
  • Rare Disease
  • Gastroenterology
Phases
  • Preclinical (General)
  • Discovery
  • Discovery
  • Preclinical (General)
Sourcing modelsData not yet provided.
  • Full-Service Outsourcing (FSO)
Locations
  • Headquarters
  • Nanjing, Nanjing, China
  • Shanghai, Shanghai, China
  • Philadelphia, Philadelphia, Pennsylvania, United States
CertificationsData not yet provided.Data not yet provided.

Find similar companies

STEMCELL Technologies Inc. alternatives · TRiCBIO alternatives

Markdown mirror: /compare/stemcell/tricbio.md